Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ferré

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Journal of Neurochemistry|January 5, 2000
Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cellsH Salim, S Ferré, A Dalal, et al.
Neuroscience Letters|August 15, 1994
PEC-60 increases dopamine but not GABA release in the dorsolateral neostriatum of the halothane anaesthetized rat. An in vivo microdialysis studyR Rimondini, W T O'Connor, S Ferré, et al.
British Journal of Pharmacology|November 27, 2007
G-protein-coupled receptor heteromers: function and ligand pharmacologyR Franco, V Casadó, A Cortés, et al.
Veterinary Microbiology|January 21, 2012
Pre-infection of pigs with Mycoplasma hyopneumoniae modifies outcomes of infection with European swine influenza virus of H1N1, but not H1N2, subtypeC Deblanc, S Gorin, S Quéguiner, et al.
Neuroreport|December 30, 1994
Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptorsS Ferré, P Popoli, L Giménez-Llort, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 7, 2006
Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteinsR Franco, C Lluis, E I Canela, et al.
Neurochemistry International|March 1, 1992
Neuropeptides, excitatory amino acid and adenosine A2 receptors regulate D2 receptors via intramembrane receptor-receptor interactions. Relevance for Parkinson's disease and schizophreniaK Fuxe, L F Agnati, G von Euler, et al.
Parkinsonism & Related Disorders|May 2, 2001
Adenosine/dopamine interaction: implications for the treatment of Parkinson's diseaseS Ferré, P Popoli, L Giménez-Llort, et al.
European Journal of Pharmacology|April 25, 1990
Paraxanthine displaces the binding of [3H]SCH 23390 from rat striatal membranesS Ferré, T Guix, J Sallés, et al.
Genes, Brain, and Behavior|October 21, 2017
Behavioral control by striatal adenosine A<sub>2A</sub> -dopamine D<sub>2</sub> receptor heteromersJ Taura, M Valle-León, K Sahlholm, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Journal of Neurochemistry|January 5, 2000
Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cellsH Salim, S Ferré, A Dalal, et al.
Neuroscience Letters|August 15, 1994
PEC-60 increases dopamine but not GABA release in the dorsolateral neostriatum of the halothane anaesthetized rat. An in vivo microdialysis studyR Rimondini, W T O'Connor, S Ferré, et al.
British Journal of Pharmacology|November 27, 2007
G-protein-coupled receptor heteromers: function and ligand pharmacologyR Franco, V Casadó, A Cortés, et al.
Veterinary Microbiology|January 21, 2012
Pre-infection of pigs with Mycoplasma hyopneumoniae modifies outcomes of infection with European swine influenza virus of H1N1, but not H1N2, subtypeC Deblanc, S Gorin, S Quéguiner, et al.
Neuroreport|December 30, 1994
Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptorsS Ferré, P Popoli, L Giménez-Llort, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 7, 2006
Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteinsR Franco, C Lluis, E I Canela, et al.
Neurochemistry International|March 1, 1992
Neuropeptides, excitatory amino acid and adenosine A2 receptors regulate D2 receptors via intramembrane receptor-receptor interactions. Relevance for Parkinson's disease and schizophreniaK Fuxe, L F Agnati, G von Euler, et al.
Parkinsonism & Related Disorders|May 2, 2001
Adenosine/dopamine interaction: implications for the treatment of Parkinson's diseaseS Ferré, P Popoli, L Giménez-Llort, et al.
European Journal of Pharmacology|April 25, 1990
Paraxanthine displaces the binding of [3H]SCH 23390 from rat striatal membranesS Ferré, T Guix, J Sallés, et al.
Genes, Brain, and Behavior|October 21, 2017
Behavioral control by striatal adenosine A<sub>2A</sub> -dopamine D<sub>2</sub> receptor heteromersJ Taura, M Valle-León, K Sahlholm, et al.
Pageof 9